Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -23.46-24.787.6324.25407.44

What is the latest Core EBITDA Growth ratio of BALAXI PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of BALAXI PHARMACEUTICALS is -23.46 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-23.46
Mar2024-24.78
Mar20237.63
Mar202224.25
Mar2021407.44

How is Core EBITDA Growth of BALAXI PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -23.46
Negative
Mar2024 -24.78
Negative
Mar2023 7.63
-68.54
Mar2022 24.25
-94.05
Mar2021 407.44 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹115.1 Cr -5.4% -15.7% -67.9% Stock Analytics
ADANI ENTERPRISES ₹289,852.0 Cr 0.4% 4.9% -3% Stock Analytics
REDINGTON ₹20,384.8 Cr -3% -1.1% 10.7% Stock Analytics
HONASA CONSUMER ₹9,795.3 Cr 2.9% 6% 52.3% Stock Analytics
MMTC ₹9,529.5 Cr -4.1% -7.4% -0.7% Stock Analytics
LLOYDS ENTERPRISES ₹8,736.5 Cr -1.4% 1.7% 23.8% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-5.4%

-15.7%

-67.9%

SENSEX

-1%

-0.1%

7.9%


You may also like the below Video Courses